Escheriosome-mediated cytosolic delivery of PLK1-specific siRNA: potential in treatment of liver cancer in BALB/c mice.
about
Immunotherapy for Bone and Soft Tissue SarcomasDelivery strategies and potential targets for siRNA in major cancer typesNanoparticle-Based Mycosis Vaccine.miR-451a Inhibited Cell Proliferation and Enhanced Tamoxifen Sensitive in Breast Cancer via Macrophage Migration Inhibitory FactorMultifunctional nanosystems: growing sanguinity in siRNA therapy.
P2860
Escheriosome-mediated cytosolic delivery of PLK1-specific siRNA: potential in treatment of liver cancer in BALB/c mice.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Escheriosome-mediated cytosoli ...... f liver cancer in BALB/c mice.
@en
Escheriosome-mediated cytosoli ...... f liver cancer in BALB/c mice.
@nl
type
label
Escheriosome-mediated cytosoli ...... f liver cancer in BALB/c mice.
@en
Escheriosome-mediated cytosoli ...... f liver cancer in BALB/c mice.
@nl
prefLabel
Escheriosome-mediated cytosoli ...... f liver cancer in BALB/c mice.
@en
Escheriosome-mediated cytosoli ...... f liver cancer in BALB/c mice.
@nl
P2093
P2860
P356
P1433
P1476
Escheriosome-mediated cytosoli ...... f liver cancer in BALB/c mice.
@en
P2093
Arun Chauhan
Mohammad Yunus Ansari
Owais Mohammad
Sajid Ali Ansari
Swaleha Zubair
P2860
P304
P356
10.2217/NNM.13.21
P50
P577
2014-04-01T00:00:00Z